Academic Journal

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo

التفاصيل البيبلوغرافية
العنوان: Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
المؤلفون: Schwab, C L, Bellone, S, English, D P, Roque, D M, Lopez, S, Cocco, E, Nicoletti, R, Bortolomai, I, Bonazzoli, E, Ratner, E, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Santin, A D
المصدر: British Journal of Cancer ; volume 111, issue 9, page 1750-1756 ; ISSN 0007-0920 1532-1827
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2014
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/bjc.2014.519
الاتاحة: http://dx.doi.org/10.1038/bjc.2014.519
http://www.nature.com/articles/bjc2014519.pdf
http://www.nature.com/articles/bjc2014519
Rights: http://www.springer.com/tdm
رقم الانضمام: edsbas.32CDDC79
قاعدة البيانات: BASE